Long-term safety and sustained efficacy of USL255 (topiramate extended-release capsules) in patients with refractory partial-onset seizures-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term safety and sustained efficacy of USL255 (topiramate extended-release capsules) in patients with refractory partial-onset seizures

Published:2016-06 Issue: Volume:59 Page:13-20
ISSN:1525-5050
Container-title:Epilepsy & Behavior
language:en
Short-container-title:Epilepsy & Behavior

Author:

Chung Steve S.,Hogan R. Edward,Blatt Ilan,Lawson P. Balduin,Nguyen Huy,Clark Annie M.,Anders Bob,Halvorsen Mark B.

Funder

Upsher-Smith Laboratories, Inc.

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Clinical Neurology,Neurology

Reference28 articles.

1. Combining antiepileptic drugs — rational polytherapy?;Brodie;Seizure,2011

2. Road to refractory epilepsy: the Glasgow story;Brodie;Epilepsia,2013

3. The psychosocial burden of epilepsy;Baker;Epilepsia,2002

4. Qudexy® XR (topiramate) extended-release capsules. Prescribing information,2015

5. Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation;Bialer;Epilepsia,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cenobamate as an Early Adjunctive Treatment in Drug-Resistant Focal-Onset Seizures: An Observational Cohort Study;CNS Drugs;2024-08-03

2. Long‐term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program;Epilepsia;2021-11-23

3. Long‐term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open‐label extension of a randomized clinical study;Epilepsia;2021-07-13

4. Usefulness of extended‐release topiramate in patients with epilepsy: A two‐year retention study;Journal of Clinical Pharmacy and Therapeutics;2021-06-19

5. Topiramate add-on therapy for drug-resistant focal epilepsy;Cochrane Database of Systematic Reviews;2019-10-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3